Thursday, March 28, 2024
Home Tags BIO CEO & Investor Contact

Tag: BIO CEO & Investor Contact

Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing...

0
NORCROSS, Ga., April 13, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins,...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News